Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
13%
Ph phase_2
1
13%
Ph phase_4
3
38%
Ph phase_3
2
25%
Ph not_applicable
1
13%

Phase Distribution

1

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
3(37.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(2)
Other(4)

Detailed Status

unknown4
Completed2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (12.5%)
Phase 21 (12.5%)
Phase 32 (25.0%)
Phase 43 (37.5%)
N/A1 (12.5%)

Trials by Status

not_yet_recruiting113%
recruiting113%
unknown450%
completed225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8